Paper428146
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
Thatcher N and 2 others. Clin Exp Immunol, 1979. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations. Papers, record 428146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/428146
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Bacterial Vaccines | Major topic |
| Melanoma | Major topic |
| Propionibacterium acnes | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Immunoglobulins | |
| Leukocyte Count | |
| Lymphocyte Activation | |
| Male | |
| Middle Aged | |
| Phytohemagglutinins | |
| Receptors, Antigen, B-Cell | |
| Rosette Formation |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 186417 | Immunological monitoring and immunotherapy in carcinoma of the lung. | Int J Cancer | 1976 | https://conductscience.org/library/papers/186417 | PubMed |
| 2 | 137880 | Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy. | Int J Cancer | 1977 | https://conductscience.org/library/papers/137880 | PubMed |
| 3 | 300303 | The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/300303 | PubMed |
| 4 | 597473 | Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. | Br J Cancer | 1977 | https://conductscience.org/library/papers/597473 | PubMed |
| 5 | 588989 | Postoperative depression of lymphocyte transformation response to microbial antigens. | Br J Surg | 1977 | https://conductscience.org/library/papers/588989 | PubMed |
| 6 | 4276248 | Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. | Cancer Res | 1974 | https://conductscience.org/library/papers/4276248 | PubMed |
| 7 | 1098195 | Immunodepression after major surgery in normal patients. | Surgery | 1975 | https://conductscience.org/library/papers/1098195 | PubMed |
| 8 | 4574043 | Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. | Br Med J | 1973 | https://conductscience.org/library/papers/4574043 | PubMed |
| 9 | 1084821 | The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer. | Clin Exp Immunol | 1976 | https://conductscience.org/library/papers/1084821 | PubMed |
| 10 | 769946 | Monitoring of immunologic status of patients receiving BCG therapy for malignant disease. | Cancer | 1976 | https://conductscience.org/library/papers/769946 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7387858 | Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7387858 | PubMed |
| 7326194 | Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7326194 | PubMed |
| 487647 | Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/487647 | PubMed |
| 312169 | Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/312169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/428146
GET https://conductscience.org/api/papers/v1/428146/authors